CanaFarma Hemp Products Corp
CanaFarma Hemp Products Corp. engages in growing, manufacturing, processing, and selling hemp oil in the United States. The company offers hemp-based products, such as chewing gum and tincture under the YOOFORIC brand. It offers its products online. The company is based in Vancouver, Canada.
CanaFarma Hemp Products Corp (CNFHF) - Net Assets
Latest net assets as of March 2021: $-636.89K USD
Based on the latest financial reports, CanaFarma Hemp Products Corp (CNFHF) has net assets worth $-636.89K USD as of March 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.83 Million) and total liabilities ($2.47 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-636.89K |
| % of Total Assets | -34.82% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 20191.74 |
CanaFarma Hemp Products Corp - Net Assets Trend (2018–2020)
This chart illustrates how CanaFarma Hemp Products Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CanaFarma Hemp Products Corp (2018–2020)
The table below shows the annual net assets of CanaFarma Hemp Products Corp from 2018 to 2020.
| Year | Net Assets | Change |
|---|---|---|
| 2020-06-30 | $-99.01K | -102.21% |
| 2019-06-30 | $4.49 Million | +40281.28% |
| 2018-06-30 | $11.12K | -- |
Equity Component Analysis
This analysis shows how different components contribute to CanaFarma Hemp Products Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2020426244.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2020)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $22.79 Million | % |
| Other Comprehensive Income | $-2.68 Million | % |
| Total Equity | $-99.01K | 100.00% |
CanaFarma Hemp Products Corp Competitors by Market Cap
The table below lists competitors of CanaFarma Hemp Products Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
224810
KO:224810
|
$14.58K |
|
VisionWave Holdings, Inc. Warrant
NASDAQ:VWAVW
|
$14.59K |
|
Propellus Inc
PINK:PRPS
|
$14.60K |
|
CASI PHARMAC. NEW O.N.
F:ENM
|
$14.61K |
|
CHINA OVS LD & INV
MU:CPP
|
$14.54K |
|
NATIONAL INVESTMENT COMPANY LIMITED
DSE:NICO
|
$14.53K |
|
Trufin PLC
LSE:TRU
|
$14.52K |
|
GOLDQUEST MINING
MU:M1W
|
$14.51K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CanaFarma Hemp Products Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2019 to 2020, total equity changed from 4,577,131 to -99,008, a change of -4,676,139 (-102.2%).
- Net loss of 17,546,739 reduced equity.
- New share issuances of 6,377,000 increased equity.
- Other comprehensive income decreased equity by 14,046,125.
- Other factors increased equity by 20,539,725.
Equity Change Factors (2019 to 2020)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-17.55 Million | -17722.55% |
| Share Issuances | $6.38 Million | +6440.89% |
| Other Comprehensive Income | $-14.05 Million | -14186.86% |
| Other Changes | $20.54 Million | +20745.52% |
| Total Change | $- | -102.16% |
Book Value vs Market Value Analysis
This analysis compares CanaFarma Hemp Products Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-06-30 | $0.00 | $0.00 | x |
| 2019-06-30 | $0.02 | $0.00 | x |
| 2020-06-30 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CanaFarma Hemp Products Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -986.67%
- • Asset Turnover: 0.26x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-21.22%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -63.09% | 0.00% | 0.00x | 1.25x | $-8.13K |
| 2019 | -0.57% | -45.63% | 0.01x | 1.09x | $-483.64K |
| 2020 | 0.00% | -986.67% | 0.26x | 0.00x | $-17.54 Million |
Industry Comparison
This section compares CanaFarma Hemp Products Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CanaFarma Hemp Products Corp (CNFHF) | $-636.89K | -63.09% | N/A | $14.56K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |